These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21724730)

  • 1. Serum levels of HMGB1 in postmenopausal patients with rheumatoid arthritis: associations with proinflammatory cytokines, acute-phase reactants, and clinical disease characteristics.
    Pullerits R; Urbonaviciute V; Voll RE; Forsblad-D'Elia H; Carlsten H
    J Rheumatol; 2011 Jul; 38(7):1523-5. PubMed ID: 21724730
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study.
    Lutf A; Poil AR; Hammoudeh M
    Int J Rheum Dis; 2014 Jan; 17(1):63-5. PubMed ID: 24472269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined measurement of multiple acute phase reactants to predict relapse of rheumatoid arthritis.
    Lv F; Song LJ; Li XF
    Int J Rheum Dis; 2015 Sep; 18(7):725-30. PubMed ID: 24131533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multibiomarker disease activity score for rheumatoid arthritis predicts radiographic joint damage in the BeSt study.
    Markusse IM; Dirven L; van den Broek M; Bijkerk C; Han KH; Ronday HK; Bolce R; Sasso EH; Kerstens PJ; Lems WF; Huizinga TW; Allaart CF
    J Rheumatol; 2014 Nov; 41(11):2114-9. PubMed ID: 25128518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis.
    Shimamoto K; Ito T; Ozaki Y; Amuro H; Tanaka A; Nishizawa T; Son Y; Inaba M; Nomura S
    J Rheumatol; 2013 Jul; 40(7):1074-81. PubMed ID: 23637318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of combined therapy of rheumatoid arthritis on the acute phase reactants.
    Rexhepi S; Rexhepi M; Sahatçiu-Meka V; Pllana E; Dragusha G; Gashi M; Rexhepi B
    Reumatizam; 2009; 56(2):77-80. PubMed ID: 20429264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The power Doppler ultrasonography score from 24 synovial sites or 6 simplified synovial sites, including the metacarpophalangeal joints, reflects the clinical disease activity and level of serum biomarkers in patients with rheumatoid arthritis.
    Kawashiri SY; Kawakami A; Iwamoto N; Fujikawa K; Satoh K; Tamai M; Nakamura H; Okada A; Koga T; Yamasaki S; Ida H; Origuchi T; Eguchi K
    Rheumatology (Oxford); 2011 May; 50(5):962-5. PubMed ID: 21186172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological disease modifying anti-rheumatic drugs.
    Mamehara A; Sugimoto T; Sugiyama D; Morinobu S; Tsuji G; Kawano S; Morinobu A; Kumagai S
    Kobe J Med Sci; 2010 Sep; 56(3):E98-107. PubMed ID: 21063156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observational cross-sectional study revealing less aggressive treatment in Japanese elderly than nonelderly patients with rheumatoid arthritis.
    Ogasawara M; Tamura N; Onuma S; Kusaoi M; Sekiya F; Matsudaira R; Kempe K; Yamaji K; Takasaki Y
    J Clin Rheumatol; 2010 Dec; 16(8):370-4. PubMed ID: 21085019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining erosive disease typical of RA in the light of the ACR/EULAR 2010 criteria for rheumatoid arthritis; results of the data driven phase.
    Knevel R; Lukas C; van der Heijde D; Rincheval N; Combe B; van der Helm-van Mil AH
    Ann Rheum Dis; 2013 Apr; 72(4):590-5. PubMed ID: 23393145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs.
    Kawashiri SY; Kawakami A; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Arima K; Kamachi M; Yamasaki S; Nakamura H; Tsurumoto T; Kono M; Shindo H; Ida H; Origuchi T; Eguchi K
    J Rheumatol; 2009 Nov; 36(11):2397-402. PubMed ID: 19797510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of the HLA shared epitope for severity of radiological joint damage in patients with rheumatoid arthritis. A 10 year observational prospective study.
    Valenzuela-Castaño A; García-López A; Pérez-Vilches D; Rodriguez-Pérez R; Gonzalez-Escribano MF; Núñez-Roldán A
    J Rheumatol; 2000 Mar; 27(3):571-4. PubMed ID: 10743791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of understanding radiographic findings in relation to clinical outcomes in rheumatoid arthritis.
    Keystone EC
    J Rheumatol Suppl; 2009 Jun; 82():11-6. PubMed ID: 19509325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.
    Chen HA; Lin KC; Chen CH; Liao HT; Wang HP; Chang HN; Tsai CY; Chou CT
    Ann Rheum Dis; 2006 Jan; 65(1):35-9. PubMed ID: 15975966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change of synovial vascularity in a single finger joint assessed by power doppler sonography correlated with radiographic change in rheumatoid arthritis: comparative study of a novel quantitative score with a semiquantitative score.
    Fukae J; Kon Y; Henmi M; Sakamoto F; Narita A; Shimizu M; Tanimura K; Matsuhashi M; Kamishima T; Atsumi T; Koike T
    Arthritis Care Res (Hoboken); 2010 May; 62(5):657-63. PubMed ID: 20191472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in Remission According to Different Criteria in Patients with Rheumatoid Arthritis.
    Yilmaz-Oner S; Ozen G; Can M; Atagunduz P; Direskeneli H; Inanc N
    J Rheumatol; 2015 Nov; 42(11):2066-70. PubMed ID: 26472417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants.
    van Leeuwen MA; van der Heijde DM; van Rijswijk MH; Houtman PM; van Riel PL; van de Putte LB; Limburg PC
    J Rheumatol; 1994 Mar; 21(3):425-9. PubMed ID: 7516430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic joint.
    Meeuwisse CM; van der Linden MP; Rullmann TA; Allaart CF; Nelissen R; Huizinga TW; Garritsen A; Toes RE; van Schaik R; van der Helm-van Mil AH
    Arthritis Rheum; 2011 May; 63(5):1265-73. PubMed ID: 21305530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
    Ballara S; Taylor PC; Reusch P; Marmé D; Feldmann M; Maini RN; Paleolog EM
    Arthritis Rheum; 2001 Sep; 44(9):2055-64. PubMed ID: 11592367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of biomarkers in diagnostics and forecasting of effectiveness of modern therapy of rheumatoid arthritis].
    Aleksandrova EN; Novikov AA; Nasonov EL
    Klin Lab Diagn; 2013 Aug; (8):3-13. PubMed ID: 24340741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.